Literature DB >> 7048364

The use of mucosa-lined flaps in eyelid reconstruction: a new approach.

J C van der Meulen.   

Abstract

In this paper, a review is given of the conditions that should be fulfilled for optimal eyelid reconstruction and of the principles on which modern techniques are based. A new approach to upper-eyelid reconstruction using a bipedicled flap from the lower eyelid that is lined with a mucosal graft but has no cartilaginous support is described. Also introduced is the use of similarly lined monopedicled flaps for the reconstruction of lower-eyelid defects. With these procedures, eyelid reconstruction has become less complicated. Flaps taken from forehead or cheek are scarcely ever necessary, and problems with reconstruction can be restricted to patients who have had radiotherapy or to the rare patients in whom defects in both eyelids have to be closed.

Entities:  

Mesh:

Year:  1982        PMID: 7048364     DOI: 10.1097/00006534-198208000-00001

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Facial clefts.

Authors:  J C van der Meulen; J M Vaandrager
Journal:  World J Surg       Date:  1989 Jul-Aug       Impact factor: 3.352

2.  Total upper eyelid reconstruction by single staged malar-cheek flap.

Authors:  Rajeev B Ahuja; Pallab Chatterjee; Gaurav K Gupta; Prabhat Shrivastava
Journal:  Indian J Plast Surg       Date:  2014-01

3.  Aesthetic Total Reconstruction of Lower Eyelid Using Scapha Cartilage Graft on a Vascularized Propeller Flap.

Authors:  Tetsuji Uemura; Hidekata Watanabe; Kazuyuki Masumoto; Mamoru Kikuchi; Yoshiyasu Satake; Tetsu Yanai; Yoshimi Harada; Yasuhiro Ishihara; Masato Yasuta
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-04-26

4.  Total or subtotal replacement of tarsal plate by novel silicone plate for upper eyelid reconstruction in malignant tumors.

Authors:  Salil Kumar Mandal; Basupurna Majumdar; Purban Ganguly; Stephen C Dryden; James C Fleming; Brian T Fowler
Journal:  Indian J Ophthalmol       Date:  2021-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.